Lowest Price Guaranteed
Pages
212
Last Updated
September 2026
View Count
29359
1. PREFACE
1.1. Chapter Overview
1.2. Market Segmentations
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Artificial Intelligence in Digital Pathology
3.3. Workflow of AI-based Digital Pathology
3.4. Applications of AI-based Digital Pathology Solutions
3.5. Regulatory Requirements Focused on AI-based Digital Pathology:
3.6. Challenges Associated with the Use of AI in Digital Pathology
3.7. Future Perspectives
4. AI-BASED DIGITAL PATHOLOGY: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. AI-based Digital Pathology Providers: Overall Market Landscape
4.2.1. Analysis by Type of Product
4.2.2. Analysis by Type of Service Offered
4.2.3. Analysis by Type of Feature
4.2.4. Analysis by Additional Features
4.2.5. Analysis by Target Disease Indication
4.2.6. Analysis by Type of Assay
4.2.7. Analysis by Area of Application
4.2.8. Analysis by Type of End-user
4.2.9. Analysis by Number of Available Software
4.3. AI-based Digital Pathology Providers: Developer Landscape
4.3.1. Analysis by Geographical Reach
4.3.2. Analysis by Year of Establishment
4.3.3. Analysis by Company Size
4.3.4. Analysis by Location of Headquarters (Country-wise)
4.3.5. Analysis by Location of Headquarters (Continent-wise)
5. AI-BASED DIGITAL PATHOLOGY MARKET: KEY INSIGHTS
5.1. Chapter Overview
5.1.1. Analysis by Type of Service and Area of Application
5.1.2. Analysis by Type of Feature and Area of Application
5.1.3. Analysis by Type of Product and Area of Application
5.1.4. Analysis by Type of Product and Location of Headquarters
5.1.5. Analysis by Company Size and Location of Headquarters
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. PathAI
6.2.1. Company Overview
6.2.2. Recent Developments and Future Outlook
6.3. Paige
6.3.1. Company Overview
6.3.2. Recent Developments and Future Outlook
6.4. Akoya Biosciences
6.4.1. Company Overview
6.4.2. Recent Developments and Future Outlook
6.5. PROSCIA
6.5.1. Company Overview
6.5.2. Recent Developments and Future Outlook
6.6. Visiopharm
6.6.1. Company Overview
6.6.2. Recent Developments and Future Outlook
6.7. Roche Tissue Diagnostics
6.7.1. Company Overview
6.7.2. Recent Developments and Future Outlook
6.8. Aiforia Technologies
6.8.1. Company Overview
6.8.2. Recent Developments and Future Outlook
6.9. Indica Labs
6.9.1. Company Overview
6.9.2. Recent Developments and Future Outlook
6.10. Ibex Medical Analytics
6.10.1. Company Overview
6.10.2. Recent Developments and Future Outlook
7. COMPANY COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Benchmarking of Portfolio Strength
7.5. Benchmarking of Funding Strength
7.6. Company Competitiveness Analysis: Small Players
7.7. Company Competitiveness Analysis: Mid-sized Players
7.8. Company Competitiveness Analysis: Large Players
8. FUNDING AND INVESTMENTS
8.1. Chapter Overview
8.2. Types of Funding
8.3. AI-based Digital Pathology: List of Funding and Investments
8.3.1. Cumulative Year-wise Trend by Number of Instances
8.3.2. Cumulative Year-wise Trend by Amount Invested
8.3.3. Analysis by Type of Funding
8.3.4. Analysis by Type of Funding and Amount Invested
8.3.5. Analysis by Area of Application
8.3.6. Analysis by Geography
8.3.7. Most Active Players: Analysis by Number of Funding Instances
8.3.8. Most Active Players: Analysis by Amount Raised
8.4. Concluding Remarks
9. DEMAND ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Global Demand for AI-based Digital Pathology, 2022-2035
9.4. Demand for AI-based Digital Pathology: Analysis by Geography
9.4.1. Demand for AI-based Digital Pathology in North America
9.4.1.1 Demand for AI-based Digital Pathology in the US
9.4.1.2 Demand for AI-based Digital Pathology in Canada
9.4.2. Demand for AI-based Digital Pathology in Europe
9.4.2.1. Demand for AI-based Digital Pathology in UK
9.4.2.2. Demand for AI-based Digital Pathology in Germany
9.4.2.3. Demand for AI-based Digital Pathology in Spain
9.4.2.4. Demand for AI-based Digital Pathology in Italy
9.4.2.5. Demand for AI-based Digital Pathology in France
9.4.3. Demand for AI-based Digital Pathology in Asia
9.4.3.1. Demand for AI-based Digital Pathology in China
9.4.3.2. Demand for AI-based Digital Pathology in Japan
9.4.3.3. Demand for AI-based Digital Pathology in South Korea
9.4.4. Demand for AI-based Digital Pathology in Latin America
9.4.4.1. Demand for AI-based Digital Pathology in Brazil
9.4.5. Demand for AI-based Digital Pathology in MENA
9.4.5.1. Demand for AI-based Digital Pathology in Saudi Arabia
9.4.6. Demand for AI-based Digital Pathology in Rest of the World
9.4.6.1. Demand for AI-based Digital Pathology in Australia
9.5. Demand for AI-based Digital Pathology: Analysis by Type of End-user
9.5.1 Demand for AI-based Digital Pathology in Hospitals
9.5.2. Demand for AI-based Digital Pathology in Research Institutes
9.5.3. Demand for AI-based Digital Pathology in Other End-users
9.6. Concluding Remarks
10. MARKET SIZING AND OPPORTUNITY ANALYSIS
10.1. Chapter Overview
10.2. Forecast Methodology and Key Assumptions
10.3. Global AI-based Digital Pathology Market, 2022-2035
10.4. AI-based Digital Pathology Market: Analysis by Type of Neural Network, 2022 and 2035
10.4.1. AI-based Digital Pathology Market for Artificial Neural Network, 2022-2035
10.4.2. AI-based Digital Pathology Market for Convolutional Neural Network, 2022-2035
10.4.3. AI-based Digital Pathology Market for Fully Convolutional Network, 2022-2035
10.4.4. AI-based Digital Pathology Market for Recurrent Neural Network, 2022 – 2035
10.4.5. AI-based Digital Pathology Market for Other Neural Networks, 2022 – 2035
10.5. AI-based Digital Pathology Market: Analysis by Type of Assay, 2022 and 2035
10.5.1. AI-based Digital Pathology Market for ER Assay, 2022-2035
10.5.2. AI-based Digital Pathology Market for HER2 Assay, 2022-2035
10.5.3. AI-based Digital Pathology Market for Ki67 Assay, 2022-2035
10.5.4. AI-based Digital Pathology Market for PD-L1 Assay, 2022-2035
10.5.5. AI-based Digital Pathology Market for PR Assay, 2022-2035
10.5.6. AI-based Digital Pathology Market for Other Type of Assays, 2022-2035
10.6. AI-based Digital Pathology Market: Analysis by Type of End-user, 2022 and 2035
10.6.1. AI-based Digital Pathology Market for Academic Institutions, 2022-2035
10.6.2. AI-based Digital Pathology Market for Hospitals / Healthcare Institutions, 2022-2035
10.6.3. AI-based Digital Pathology Market for Laboratories / Diagnostic Institutions, 2022-2035
10.6.4. AI-based Digital Pathology Market for Research Institutes, 2022-2035
10.6.5. AI-based Digital Pathology Market for Other End-users, 2022-2035
10.7. AI-based Digital Pathology Market: Analysis by Area of Application, 2022 and 2035
10.7.1. AI-based Digital Pathology Market for Diagnostics, 2022-2035
10.7.2. AI-based Digital Pathology Market for Research, 2022-2035
10.7.3. AI-based Digital Pathology Market for Other Areas of Application, 2022-2035
10.8. AI-based Digital Pathology Market: Analysis by Target Disease Indication, 2022 and 2035
10.8.1. AI-based Digital Pathology Market for Breast Cancer, 2022-2035
10.8.2. AI-based Digital Pathology Market for Colorectal Cancer, 2022-2035
10.8.3. AI-based Digital Pathology Market for Cervical Cancer, 2022-2035
10.8.4. AI-based Digital Pathology Market for Gastrointestinal Cancer, 2022-2035
10.8.5. AI-based Digital Pathology Market for Lung Cancer, 2022-2035
10.8.6. AI-based Digital Pathology Market for Prostate Cancer, 2022-2035
10.8.7. AI-based Digital Pathology Market for Other Indications, 2022-2035
10.9. AI-based Digital Pathology Market: Analysis by Key Geographies, 2022 and 2035
10.9.1. AI-based Digital Pathology Market in North America, 2022-2035
10.9.1.1. AI-based Digital Pathology Market in the US, 2022-2035
10.9.1.2. AI-based Digital Pathology Market in Canada, 2022-2035
10.9.2. AI-based Digital Pathology Market in Europe, 2022-2035
10.9.2.1. AI-based Digital Pathology Market in UK, 2022-2035
10.9.2.2. AI-based Digital Pathology Market in Germany, 2022-2035
10.9.2.3. AI-based Digital Pathology Market in Spain, 2022-2035
10.9.2.4. AI-based Digital Pathology Market in Italy, 2022-2035
10.9.2.5. AI-based Digital Pathology Market in France, 2022-2035
10.9.3. AI-based Digital Pathology Market in Asia, 2022-2035
10.9.3.1. AI-based Digital Pathology Market in China, 2022-2035
10.9.3.2. AI-based Digital Pathology Market in Japan, 2022-2035
10.9.3.3. AI-based Digital Pathology Market in South Korea, 2022-2035
10.9.4. AI-based Digital Pathology Market in Latin America, 2022-2035
10.9.4.1. AI-based Digital Pathology Market in Brazil, 2022 – 2035
10.9.5. AI-based Digital Pathology Market in MENA, 2022-2035
10.9.5.1. AI-based Digital Pathology Market in Saudi Arabia, 2022-2035
10.9.6. AI-based Digital Pathology Market in Rest of the World, 2022-2035
10.9.6.1. AI-based Digital Pathology Market in Australia, 2022-2035
11. CONCLUDING REMARKS
12. EXECUTIVE INSIGHTS
12.1. Chapter Overview
12.2. aetherAI
12.2.1. Company Snapshot
12.2.2. Interview Transcript: Joe Yeh (Chief Executive Officer and Chairman)
12.3. CTL Clinitech Lab
12.3.1. Company Snapshot
12.3.2. Interview Transcript: Suraj Bramhane (Laboratory Director and Chief Pathologist)
12.4. Huron Digital Pathology
12.4.1. Company Snapshot
12.4.2. Interview Transcript: Savvas Damaskinos (Vice President, Research and Technology)
12.5. Mindpeak
12.5.1. Company Snapshot
12.5.2. Interview Transcript: Anil Berger (Vice President, Sales and Marketing)
13. APPENDIX 1: TABULATED DATA
14. APPENDIX II: LIST OF COMPANIES AND ORGANIZATION
Figure 2.1 Executive Summary: Market Landscape
Figure 2.2 Executive Summary: Key Insights
Figure 2.3 Executive Summary: Funding and Investments
Figure 2.4 Executive Summary: Demand Analysis
Figure 2.5 Executive Summary: Market Sizing and Opportunity Analysis
Figure 3.1 Workflow of AI-based Digital Pathology
Figure 3.2 Applications of AI-based Digital Pathology Solutions
Figure 4.1 AI-based Digital Pathology Providers: Distribution by Type of Product
Figure 4.2 AI-based Digital Pathology Providers: Distribution by Type of Service Offered
Figure 4.3 AI-based Digital Pathology Providers: Distribution by Type of Feature
Figure 4.4 AI-based Digital Pathology Providers: Distribution by Additional Features
Figure 4.5 AI-based Digital Pathology Providers: Distribution by Target Disease Indication
Figure 4.6 AI-based Digital Pathology Providers: Distribution by Type of Assay
Figure 4.7 AI-based Digital Pathology Providers: Distribution by Area of Application
Figure 4.8 AI-based Digital Pathology Providers: Distribution by Type of End-user
Figure 4.9 AI-based Digital Pathology Providers: Distribution by Number of Available Software
Figure 4.10 AI-based Digital Pathology Providers: Distribution by Geographical Reach
Figure 4.11 AI-based Digital Pathology Providers: Distribution by Year of Establishment
Figure 4.12 AI-based Digital Pathology Providers: Distribution by Company Size
Figure 4.13 AI-based Digital Pathology Providers: Distribution by Location of Headquarters (Country-wise)
Figure 4.14 AI-based Digital Pathology Providers: Distribution by Location of Headquarters (Continent-wise)
Figure 5.1 Key Insights: Distribution by Type of Service and Area of Application
Figure 5.2 Key Insights: Distribution by Type of Feature and Area of Application
Figure 5.3 Key Insights: Distribution by Type of Product and Area of Application
Figure 5.4 Key Insights: Distribution by Type of Product and Location of Headquarters
Figure 5.5 Key Insights: Distribution by Company Size and Location of Headquarters
Figure 7.1 Company Competitiveness Analysis: Benchmarking of Portfolio Strength
Figure 7.2 Company Competitiveness Analysis: Benchmarking of Funding Strength
Figure 7.3 Company Competitiveness Analysis: Small Players
Figure 7.4 Company Competitiveness Analysis: Mid-sized Players
Figure 7.5 Company Competitiveness Analysis: Large Players
Figure 8.1 Funding and Investments: Cumulative Year-wise Trend by Number of Instances
Figure 8.2 Funding and Investments: Cumulative Year-wise Trend by Amount Invested
Figure 8.3 Funding and Investments: Distribution of Instances by Type of Funding
Figure 8.4 Funding and Investments: Distribution of Instances by Type of Funding and Amount Invested
Figure 8.5 Funding and Investments: Distribution of Instances by Area of Application
Figure 8.6 Funding and Investments: Distribution of Instances by Geography
Figure 8.7 Most Active Players: Distribution by Number of Funding Instances
Figure 8.8 Most Active Players: Distribution by Amount Raised
Figure 8.9 Funding and Investments: Concluding Remarks
Figure 9.1 Global Demand for AI-based Digital Pathology, 2022-2035 (Million Slides)
Figure 9.2 Demand for AI-based Digital Pathology: Distribution by Geography, 2022 and 2035
Figure 9.3 Demand for AI-based Digital Pathology in North America, 2022-2035 (Million Slides)
Figure 9.4 Demand for AI-based Digital Pathology in the US, 2022-2035 (Million Slides)
Figure 9.5 Demand for AI-based Digital Pathology in Canada, 2022-2035 (Million Slides)
Figure 9.6 Demand for AI-based Digital Pathology in Europe, 2022-2035 (Million Slides)
Figure 9.7 Demand for AI-based Digital Pathology in UK, 2022-2035 (Million Slides)
Figure 9.8 Demand for AI-based Digital Pathology in Germany, 2022-2035 (Million Slides)
Figure 9.9 Demand for AI-based Digital Pathology in Spain, 2022-2035 (Million Slides)
Figure 9.10 Demand for AI-based Digital Pathology in Italy, 2022-2035 (Million Slides)
Figure 9.11 Demand for AI-based Digital Pathology in France, 2022-2035 (Million Slides)
Figure 9.12 Demand for AI-based Digital Pathology in Asia, 2022-2035 (Million Slides)
Figure 9.13 Demand for AI-based Digital Pathology in China, 2022-2035 (Million Slides)
Figure 9.14 Demand for AI-based Digital Pathology in Japan, 2022-2035 (Million Slides)
Figure 9.15 Demand for AI-based Digital Pathology in South Korea, 2022-2035 (Million Slides)
Figure 9.16 Demand for AI-based Digital Pathology in Latin America, 2022-2035 (Million Slides)
Figure 9.17 Demand for AI-based Digital Pathology in Brazil, 2022-2035 (Million Slides)
Figure 9.18 Demand for AI-based Digital Pathology in MENA, 2022-2035 (Million Slides)
Figure 9.19 Demand for AI-based Digital Pathology in Saudi Arabia, 2022-2035 (Million Slides)
Figure 9.20 Demand for AI-based Digital Pathology in Rest of the World, 2022-2035 (Million Slides)
Figure 9.21 Demand for AI-based Digital Pathology in Australia, 2022-2035 (Million Slides)
Figure 9.22 Global Demand for AI-based Digital Pathology: Distribution by Type of End-user, 2022 and 2035
Figure 9.23 Global Demand for AI-based Digital Pathology in Hospitals, 2022-2035 (Million Slides)
Figure 9.24 Global Demand for AI-based Digital Pathology in Research Institutes, 2022-2035 (Million Slides)
Figure 9.25 Global Demand for AI-based Digital Pathology in Other End-users, 2022-2035 (Million Slides)
Figure 10.1 Global AI-based Digital Pathology Market, 2022-2035 (USD Million)
Figure 10.2 AI-based Digital Pathology Market: Distribution by Type of Neural Network, 2022 and 2035
Figure 10.3 AI-based Digital Pathology Market for Artificial Neural Network, 2022-2035 (USD Million)
Figure 10.4 AI-based Digital Pathology Market for Convolutional Neural Network, 2022-2035 (USD Million)
Figure 10.5 AI-based Digital Pathology Market for Fully Convolutional Network, 2022-2035 (USD Million)
Figure 10.6 AI-based Digital Pathology Market for Recurrent Neural Network, 2022-2035 (USD Million)
Figure 10.7 AI-based Digital Pathology Market for Other Neural Networks, 2022-2035 (USD Million)
Figure 10.8 AI-based Digital Pathology Market: Distribution by Type of Assay, 2022 and 2035
Figure 10.9 AI-based Digital Pathology Market for ER Assay, 2022-2035 (USD Million)
Figure 10.10 AI-based Digital Pathology Market for HER2 Assay, 2022-2035 (USD Million)
Figure 10.11 AI-based Digital Pathology Market for Ki67 Assay, 2022-2035 (USD Million)
Figure 10.12 AI-based Digital Pathology Market for PD-L1 Assay, 2022-2035 (USD Million)
Figure 10.13 AI-based Digital Pathology Market for PR Assay, 2022-2035 (USD Million)
Figure 10.14 AI-based Digital Pathology Market for Other Type of Assays, 2022-2035 (USD Million)
Figure 10.15 AI-based Digital Pathology Market: Distribution by Type of End-user, 2022 and 2035
Figure 10.16 AI-based Digital Pathology Market for Academic Institutions, 2022-2035 (USD Million)
Figure 10.17 AI-based Digital Pathology Market for Hospitals / Healthcare Institutions, 2022-2035 (USD Million)
Figure 10.18 AI-based Digital Pathology Market for Laboratories / Diagnostic Institutions, 2022-2035 (USD Million)
Figure 10.19 AI-based Digital Pathology Market for Research Institutes, 2022-2035 (USD Million)
Figure 10.20 AI-based Digital Pathology Market for Other End-users, 2022-2035 (USD Million)
Figure 10.21 AI-based Digital Pathology Market: Distribution by Area of Application, 2022 and 2035
Figure 10.22 AI-based Digital Pathology Market for Diagnostics, 2022-2035 (USD Million)
Figure 10.23 AI-based Digital Pathology Market for Research, 2022-2035 (USD Million)
Figure 10.24 AI-based Digital Pathology Market for Other Areas of Application, 2022-2035 (USD Million)
Figure 10.25 AI-based Digital Pathology Market: Distribution by Target Disease Indication, 2022 and 2035
Figure 10.26 AI-based Digital Pathology Market for Breast Cancer, 2022-2035 (USD Million)
Figure 10.27 AI-based Digital Pathology Market for Colorectal Cancer, 2022-2035 (USD Million)
Figure 10.28 AI-based Digital Pathology Market for Cervical Cancer, 2022-2035 (USD Million)
Figure 10.29 AI-based Digital Pathology Market for Gastrointestinal Cancer, 2022-2035 (USD Million)
Figure 10.30 AI-based Digital Pathology Market for Lung Cancer, 2022-2035 (USD Million)
Figure 10.31 AI-based Digital Pathology Market for Prostate Cancer, 2022-2035 (USD Million)
Figure 10.32 AI-based Digital Pathology Market for Other Indications, 2022-2035 (USD Million)
Figure 10.33 AI-based Digital Pathology Market: Distribution by Geography, 2022 and 2035
Figure 10.34 AI-based Digital Pathology Market in North America, 2022-2035 (USD Million)
Figure 10.35 AI-based Digital Pathology Market in the US, 2022-2035 (USD Million)
Figure 10.36 AI-based Digital Pathology Market in Canada, 2022-2035 (USD Million)
Figure 10.37 AI-based Digital Pathology Market in the Europe, 2022-2035 (USD Million)
Figure 10.38 AI-based Digital Pathology Market in UK, 2022-2035 (USD Million)
Figure 10.39 AI-based Digital Pathology Market in the Germany, 2022-2035 (USD Million)
Figure 10.40 AI-based Digital Pathology Market in Spain, 2022-2035 (USD Million)
Figure 10.41 AI-based Digital Pathology Market in Italy, 2022-2035 (USD Million)
Figure 10.42 AI-based Digital Pathology Market in France, 2022-2035 (USD Million)
Figure 10.43 AI-based Digital Pathology Market in Asia, 2022-2035 (USD Million)
Figure 10.44 AI-based Digital Pathology Market in China, 2022-2035 (USD Million)
Figure 10.45 AI-based Digital Pathology Market in Japan, 2022-2035 (USD Million)
Figure 10.46 AI-based Digital Pathology Market in South Korea, 2022-2035 (USD Million)
Figure 10.47 AI-based Digital Pathology Market in Latin America, 2022-2035 (USD Million)
Figure 10.48 AI-based Digital Pathology Market in Brazil, 2022-2035 (USD Million)
Figure 10.49 AI-based Digital Pathology Market in MENA, 2022-2035 (USD Million)
Figure 10.50 AI-based Digital Pathology Market in Saudi Arabia, 2022-2035 (USD Million)
Figure 10.51 AI-based Digital Pathology Market in Rest of the World, 2022-2035 (USD Million)
Figure 10.52 AI-based Digital Pathology Market in Australia, 2022-2035 (USD Million)
Figure 11.1 Concluding Remarks: Market Landscape
Figure 11.2 Concluding Remarks: Key Insights
Figure 11.3 Concluding Remarks: Funding and Investments
Figure 11.4 Concluding Remarks: Demand Analysis
Figure 11.5 Concluding Remarks: Market Sizing and Opportunity Analysis
Table 4.1 List of AI-based Digital Pathology Providers
Table 4.2 AI-based Digital Pathology Providers: Information on Type of Product
Table 4.3 AI-based Digital Pathology Providers: Information on Type of Service Offered
Table 4.4 AI-based Digital Pathology Providers: Information on Type of Feature
Table 4.5 AI-based Digital Pathology Providers: Information on Additional Features
Table 4.6 AI-based Digital Pathology Providers: Information on Area of Application
Table 4.7 AI-based Digital Pathology Providers: Information on Type of End-user
Table 6.1 AI-based Digital Pathology Providers: List of Profiled Companies
Table 6.2 PathAI: Company Snapshot
Table 6.3 PathAI: Recent Developments and Future Outlook
Table 6.4 Paige: Company Snapshot
Table 6.5 Paige: Recent Developments and Future Outlook
Table 6.6 Akoya Biosciences: Company Snapshot
Table 6.7 Akoya Biosciences: Recent Developments and Future Outlook
Table 6.8 PROSCIA: Company Snapshot
Table 6.9 PROSCIA: Recent Developments and Future Outlook
Table 6.10 Visiopharm: Company Snapshot
Table 6.11 Visiopharm: Recent Developments and Future Outlook
Table 6.12 Roche Tissue Diagnostics: Company Snapshot
Table 6.13 Roche Tissue Diagnostics: Recent Developments and Future Outlook
Table 6.14 Aiforia Technologies: Company Snapshot
Table 6.15 Aiforia Technologies: Recent Developments and Future Outlook
Table 6.16 Indica Labs: Company Snapshot
Table 6.17 Indica Labs: Recent Developments and Future Outlook
Table 6.18 Ibex Medical Analytics: Company Snapshot
Table 6.19 Ibex Medical Analytics: Recent Developments and Future Outlook
Table 8.1 AI-based Digital Pathology Providers: List of Funding and Investments
Table 12.1 aetherAI: Company Snapshot
Table 12.2 CTL Clinitech Lab: Company Snapshot
Table 12.3 Huron Digital Pathology: Company Snapshot
Table 12.4 Mindpeak: Company Snapshot
Table 12.5 Pramana: Company Snapshot
Table 13.1 AI-based Digital Pathology Providers: Distribution by Type of Product
Table 13.2 AI-based Digital Pathology Providers: Distribution by Type of Service Offered
Table 13.3 AI-based Digital Pathology Providers: Distribution by Type of Feature
Table 13.4 AI-based Digital Pathology Providers: Distribution by Additional Features
Table 13.5 AI-based Digital Pathology Providers: Distribution by Target Disease Indication
Table 13.6 AI-based Digital Pathology Providers: Distribution by Type of Assay
Table 13.7 AI-based Digital Pathology Providers: Distribution by Area of Application
Table 13.8 AI-based Digital Pathology Providers: Distribution by Type of End-User
Table 13.9 AI-based Digital Pathology Providers: Distribution by Number of Available Software
Table 13.10 AI-based Digital Pathology Providers: Distribution by Geographical Reach
Table 13.11 AI-based Digital Pathology Providers: Distribution by Year of Establishment
Table 13.12 AI-based Digital Pathology Providers: Distribution by Company Size
Table 13.13 AI-based Digital Pathology Providers: Distribution by Location of Headquarters (Country-wise)
Table 13.14 AI-based Digital Pathology Providers: Distribution by Location of Headquarters (Continent-wise)
Table 13.15 Key Insights: Distribution by Type of Service and Area of Application
Table 13.16 Key Insights: Distribution by Type of Feature and Area of Application
Table 13.17 Key Insights: Distribution by Type of Product and Area of Application
Table 13.18 Key Insights: Distribution by Type of Product and Location of Headquarters
Table 13.19 Key Insights: Distribution by Company Size and Location of Headquarters
Table 13.20 Funding and Investments: Cumulative Year-wise Trend by Number of Instances
Table 13.21 Funding and Investments: Cumulative Year-wise Trend by Amount Invested
Table 13.22 Funding and Investments: Distribution of Instances by Type of Funding
Table 13.23 Funding and Investments: Distribution of Instances by Type of Funding and Amount Invested
Table 13.24 Funding and Investments: Distribution of Instances by Area of Application
Table 13.25 Funding and Investments: Distribution of Instances by Geography
Table 13.26 Most Active Players: Distribution by Number of Funding Instances
Table 13.27 Most Active Players: Distribution by Amount Raised
Table 13.28 Funding and Investments: Concluding Remarks
Table 13.29 Global Demand for AI-based Digital Pathology, 2022-2035 (Million Slides)
Table 13.30 Demand for AI-based Digital Pathology: Distribution by Geography, 2022 and 2035
Table 13.31 Demand for AI-based Digital Pathology in North America, 2022-2035 (Million Slides)
Table 13.32 Demand for AI-based Digital Pathology in the US, 2022-2035 (Million Slides)
Table 13.33 Demand for AI-based Digital Pathology in Canada, 2022-2035 (Million Slides)
Table 13.34 Demand for AI-based Digital Pathology in Europe, 2022-2035 (Million Slides)
Table 13.35 Demand for AI-based Digital Pathology in UK, 2022-2035 (Million Slides)
Table 13.36 Demand for AI-based Digital Pathology in Germany, 2022-2035 (Million Slides)
Table 13.37 Demand for AI-based Digital Pathology in Spain, 2022-2035 (Million Slides)
Table 13.38 Demand for AI-based Digital Pathology in Italy, 2022-2035 (Million Slides)
Table 13.39 Demand for AI-based Digital Pathology in France, 2022-2035 (Million Slides)
Table 13.40 Demand for AI-based Digital Pathology in Asia, 2022-2035 (Million Slides)
Table 13.41 Demand for AI-based Digital Pathology in China, 2022-2035 (Million Slides)
Table 13.42 Demand for AI-based Digital Pathology in Japan, 2022-2035 (Million Slides)
Table 13.43 Demand for AI-based Digital Pathology in South Korea, 2022-2035 (Million Slides)
Table 13.44 Demand for AI-based Digital Pathology in Latin America, 2022-2035 (Million Slides)
Table 13.45 Demand for AI-based Digital Pathology in Brazil, 2022-2035 (Million Slides)
Table 13.46 Demand for AI-based Digital Pathology in MENA, 2022-2035 (Million Slides)
Table 13.47 Demand for AI-based Digital Pathology in Saudi Arabia, 2022-2035 (Million Slides)
Table 13.48 Demand for AI-based Digital Pathology in Rest of the World, 2022-2035 (Million Slides)
Table 13.49 Demand for AI-based Digital Pathology in Australia, 2022-2035 (Million Slides)
Table 13.50 Global Demand for AI-based Digital Pathology: Distribution by End-users, 2022 and 2035
Table 13.51 Global Demand for AI-based Digital Pathology in Hospitals, 2022-2035 (Million Slides)
Table 13.52 Global Demand for AI-based Digital Pathology in Research Institutes, 2022-2035 (Million Slides)
Table 13.53 Global Demand for AI-based Digital Pathology in Other End-users, 2022-2035 (Million Slides)
Table 13.54 Global AI-based Digital Pathology Market, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.55 AI-based Digital Pathology Market: Distribution by Type of Neural Network, 2022 and 2035
Table 13.56 AI-based Digital Pathology Market for Artificial Neural Network, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.57 AI-based Digital Pathology Market for Convolutional Neural Network, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.58 AI-based Digital Pathology Market for Fully Convolutional Network, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.59 AI-based Digital Pathology Market for Recurrent Neural Network, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.60 AI-based Digital Pathology Market for Other Neural Networks, 2022-2035, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.61 AI-based Digital Pathology Market: Distribution by Type of Assay, 2022 and 2035
Table 13.62 AI-based Digital Pathology Market for ER Assay, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.63 AI-based Digital Pathology Market for HER2 Assay, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.64 AI-based Digital Pathology Market for Ki67 Assay, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.65 AI-based Digital Pathology Market for PD-L1 Assay, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.66 AI-based Digital Pathology Market for PR Assay, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.67 AI-based Digital Pathology Market for Other Type of Assays, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.68 AI-based Digital Pathology Market: Distribution by Type of End-user, 2022 and 2035
Table 13.69 AI-based Digital Pathology Market for Academic Institutions, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.70 AI-based Digital Pathology Market for Hospitals / Healthcare Institutions, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.71 AI-based Digital Pathology Market for Laboratories / Diagnostic Institutions, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.72 AI-based Digital Pathology Market for Research Institutes, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.73 AI-based Digital Pathology Market for Other End-users, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.74 AI-based Digital Pathology Market: Distribution by Area of Application, 2022 and 2035
Table 13.75 AI-based Digital Pathology Market for Diagnostics, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.76 AI-based Digital Pathology Market for Research, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.77 AI-based Digital Pathology Market for Other Areas of Application, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.78 AI-based Digital Pathology Market: Distribution by Target Disease Indication, 2022 and 2035
Table 13.79 AI-based Digital Pathology Market for Breast Cancer, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.80 AI-based Digital Pathology Market for Colorectal Cancer, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.81 AI-based Digital Pathology Market for Cervical Cancer, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.82 AI-based Digital Pathology Market for Gastrointestinal Cancer, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.83 AI-based Digital Pathology Market for Lung Cancer, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.84 AI-based Digital Pathology Market for Prostate Cancer, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.85 AI-based Digital Pathology Market for Other Indications, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.86 AI-based Digital Pathology Market: Distribution by Key Geographies, 2022 and 2035
Table 13.87 AI-based Digital Pathology Market in North America, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.88 AI-based Digital Pathology Market in the US, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.89 AI-based Digital Pathology Market in Canada, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.90 AI-based Digital Pathology Market in the Europe, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.91 AI-based Digital Pathology Market in UK, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.92 AI-based Digital Pathology Market in the Germany, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.93 AI-based Digital Pathology Market in Spain, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.94 AI-based Digital Pathology Market in Italy, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.95 AI-based Digital Pathology Market in France, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.96 AI-based Digital Pathology Market in Asia, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.97 AI-based Digital Pathology Market in China, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.98 AI-based Digital Pathology Market in Japan, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.99 AI-based Digital Pathology Market in South Korea, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.100 AI-based Digital Pathology Market in Latin America, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.101 AI-based Digital Pathology Market in Brazil, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.102 AI-based Digital Pathology Market in MENA, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.103 AI-based Digital Pathology Market in Saudi Arabia, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.104 AI-based Digital Pathology Market in Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 13.105 AI-based Digital Pathology Market in Australia, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Please reach out to our team for the details.
Source 1: https://www.cancer.org/research/cancer-facts-statistics/global.html
Source 2: https://www.philips.co.uk/healthcare/sites/pathology/about/why-go-digital